Table 3. Total cost incurred with implementation of various screening strategies.
Screening strategy | Screening cost in million | Treatment expenditure in million | Total cost in million* | ||||
---|---|---|---|---|---|---|---|
INR | US$ | INR | US$ | INR | US$ | ||
No organized screening | 24 (16–34) | 0.38 (0.20–0.50) | 138 (72–248) | 2.08 (1.10–3.7) | 163 (96–275) | 2.45 (1.45–4.16) | |
Visual inspection with acetic acid | 3 Years | 726 (521–972) | 10.97 (7.90–14.70) | 61 (32–109) | 0.93 (0.50–1.65) | 789 (576–1046) | 11.92 (8.70–15.80) |
5 Years | 380 (276–503) | 5.74 (4.16–7.60) | 80 (41–136) | 1.20 (0.6–2.06) | 462 (348–599) | 6.98 (5.26–9.04) | |
10 Years | 221 (162–291) | 3.34 (2.4–4.4) | 98 (48–176) | 1.48 (0.75–2.5) | 319 (241–417) | 4.82 (3.64–6.3) | |
PAP smear | 3 Years | 787 (556–1103) | 11.88 (8.40–16.67) | 67 (34–127) | 1.02 (0.51–1.92) | 855 (621–1172) | 12.91 (9.37–17.71) |
5 Years | 418 (289–595) | 6.31 (3.36–9.0) | 85 (43–155) | 1.28 (0.65–2.34) | 508 (363–692) | 7.67 (5.48–10.45) | |
10 Years | 241 (166–340) | 3.64 (2.50–5.13) | 102 (51–186) | 1.54 (0.77–2.81) | 345 (246–471) | 5.21 (3.72–7.12) | |
HPV DNA test | 3 Years | 1042 (763–1436) | 15.74 (11.53–21.70) | 53 (28–97) | 0.80 (0.42–1.46) | 1101 (813–1849) | 16.64 (12.30–22.50) |
5 Years | 574 (410–803) | 8.67 (6.20–12.13) | 72 (37–130) | 1.09 (0.56–1.96) | 647 (479–880) | 9.77 (7.24–13.29) | |
10 Years | 326 (238–450) | 4.93 (3.59–6.80) | 93 (49–170) | 1.40 (0.74–2.56) | 423 (318–570) | 6.39 (4.80–8.60) |
*Total cost in a cohort of 100,000population; Pap: Papanicolaou test; Values in parenthesis represent 2.5th and 97.5th percentile; US$: Unites States Dollar; INR: Indian rupees